Health Care › Services-Medical Laboratories

ENZ Price Correlated With Financials For Enzo Biochem

Free historical financial statements for Enzo Biochem Inc. See how revenue, income, cash flow, and balance sheet financials have changed over 45 quarters since 2011. Compare with ENZ stock chart to see long term trends.

ENZ Stock Compared to Quarterly

log linear

ENZ Income Statement

Revenue, Net:

Revenue Per Share:

Cost of Goods & Services Sold:

Selling, General & Admin Expense:

Research & Development Expense:

Total Operating Expenses:

Operating Income:

Income Taxes:

Net Income:

Earnings Per Share, Basic:

Shares Outstanding, Basic Avg:

ENZ Cash Flow

Operating Activities Net Income:

Depreciation, Depletion & Amortization:

Change in Accounts Receiveable:

Net Cash from Operations:

Net Cash from Operations Per Share:

Net Cash from Financing Activities:

Property, Plant & Equipment Purchases:

Net Cash from Investing Activities:

Net Change in Cash & Equivalents:

ENZ Balance Sheet

Cash and Cash Equivalents:

Short-Term Investments:

Accounts Receivable, Net:

Inventories:

Total Current Assets:

Property, Plant & Equipment, Net:

Total Assets:

Current Portion of Long-Term Debt:

Total Short-Term Liabilities:

Long Term Debt, Non-Current Portion:

Total Liabilities:

Insider Trading

Change

Value

Transaction

SEC Form 4

Wolf James G. 10% Owner

280,000 sh at $3

$700,000

Buy

2023-01-19

Erfanian Hamid Chief Executive Officer

100,000 sh at $2

$197,000

Buy

2022-11-28

Major Holders (from 13F filings)

Investment Type

Change

Value (x$1000)

increase or decrease

Harbert Fund Advisors, Inc.

5,175,913 sh

$11,542

Renaissance Technologies LLC

2,909,664 sh

-101,500 sh
-3%

$6,489

-$2,243

Roumell Asset Management, LLC

2,390,211 sh

-2,431 sh
0%

$5,330

-$1,609

Vanguard Group Inc

1,770,749 sh

$3,949

Dimensional Fund Advisors LP

1,593,865 sh

-8,510 sh
-1%

$3,554

$237

Blackrock Inc.

1,468,121 sh

-62,134 sh
-4%

$3,275

$108

Viex Capital Advisors, LLC

1,334,479 sh

-202,378 sh
-13%

$2,976

-$205

Fuller & Thaler Asset Management, Inc.

971,010 sh

13,525 sh
1%

$2,165

$183

Potomac Capital Management, Inc.

559,500 sh

$1,248

Morgan Stanley

389,198 sh

-31,558 sh
-8%

$867

-$4

Geode Capital Management, LLC

357,544 sh

977 sh
0%

$797

$59

Bridgeway Capital Management Inc

320,700 sh

-55,000 sh
-15%

$715

-$63

Rbf Capital, LLC

250,359 sh

$559

State Street Corp

185,639 sh

$414

Northern Trust Corp

104,068 sh

-7,465 sh
-7%

$232

-$91

Bank Of New York Mellon Corp

87,281 sh

1,998 sh
2%

$194

$18

Corsair Capital Management, L.P.

75,049 sh

23 sh
0%

$167

$12

Sns Financial Group, LLC

62,500 sh

$139

Susquehanna International Group, Llp

Put options for 52,600 sh

52,600 sh
NEW

$117

Group One Trading, L.P.

51,594 sh

51,594 sh
NEW

$115

Data imported from Enzo Biochem Inc SEC filings. Check original filings before making any investment decision.